Clinical Trials on Gastrointestinal Neoplasms in Germany

Total 6864 results

Wuerzburg University Hospital

Recruiting

PSMA in Gastrointestinal Tumors (GIPSMA, Focusing on Neuroendocrine Neoplasms) (GIPSMA)

Gastrointestinal Cancer

Germany
Charite University, Berlin, Germany

Completed

Irinotecan Versus Only Best Supportive Care for Gastric Cancer

Neoplasm Metastasis | Stomach Neoplasm

Germany
Charite University, Berlin, Germany

Completed

Docetaxel and Capecitabine in Advanced Gastric Cancer

Neoplasm Metastasis | Stomach Neoplasm

Germany
Bayer

Completed

Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy (RECORA)

Colorectal Neoplasm

Germany
Apceth GmbH & Co. KG

Terminated

Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101 (TREAT-ME 1)

Advanced Gastrointestinal Cancer

Germany
Goethe University
Agaplesion Markus Krankenhaus gGmbH

Completed

Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy

Advanced Gastrointestinal Cancer

Germany
GSO Global Clinical Research BV
Karyopharm Therapeutics Inc

Terminated

Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer (SENTINEL)

Colorectal Neoplasm

Germany, Belgium
University Hospital Tuebingen

Unknown

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer (ProPeC)

Gastric Neoplasms

Germany
Kliniken Ludwigsburg-Bietigheim gGmbH

Terminated

Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)

Gastrointestinal Stromal Tumors | Gastric Neoplasms

Germany
PD Dr. med. Volker Heinemann
Merck KGaA, Darmstadt, Germany

Unknown

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

Neoplasm Metastasis | Colorectal Cancer

Germany
Chinese Academy of Sciences
City of Hope Medical Center; Fifth Affiliated Hospital, Sun Yat-Sen University and other collaborators

Recruiting

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models

Gastrointestinal Neoplasm Malignant

United States, China, Germany, Italy
Universitätsklinikum Hamburg-Eppendorf

Terminated

Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer (OLGA)

Colorectal Cancer | Metastases

Germany
Themis Bioscience GmbH
Assign Data Management and Biostatistics GmbH; Optimapharm

Withdrawn

A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract

Gastrointestinal Cancer

Germany
Technical University of Munich

Unknown

Improvement of Colonoscopy Preparation by New Media (APP) (PERICLESAPPI)

Gastrointestinal Neoplasms

Germany
Johann Wolfgang Goethe University Hospital

Unknown

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

Germany
Heidelberg University

Unknown

Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy (RELY)

Colorectal Cancer | Hepatic Metastases

Germany
Heidelberg University
Novartis Pharmaceuticals; Siemens Healthcare Diagnostics Inc; Institute of Clinical...

Completed

Unifying Advanced Treatment With Advanced Imaging (GISTm3)

Gastrointestinal Stromal Tumor (GIST)

Germany
Charite University, Berlin, Germany
German Cancer Aid

Completed

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC)

Malignant Neoplasm of Stomach | Secondary Malignant Neoplasm of Peritoneum | Secondary Malignant Neoplasm of Other and Unspecified Sites

Germany
National Center for Tumor Diseases, Heidelberg
Pfizer; Roche Pharma AG

Terminated

Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy (APRIORI)

Colorectal Carcinoma

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer

Resectable Esophageal Cancer

Germany
AIO-Studien-gGmbH
Amgen; WiSP Wissenschaftlicher Service Pharma GmbH

Completed

ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction (NEOPECX)

Stomach Neoplasms | Gastroesophageal Junction Neoplasms

Germany
Krankenhaus Nordwest

Completed

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Gastric Cancer

Germany
Hoffmann-La Roche

Completed

An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer

Gastric Cancer

Germany
Hoffmann-La Roche

Completed

Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer

Gastric Cancer

Germany
Shanghai Zhongshan Hospital
Evangelisches Krankenhaus Düsseldorf

Completed

Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer

Stomach Neoplasms

Germany
Ludwig-Maximilians - University of Munich
Sanofi

Unknown

Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer

Gastric Cancer

Germany
Johannes Gutenberg University Mainz

Completed

Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer

Gastric Cancer

Germany
Bristol-Myers Squibb

Recruiting

A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer (INGA)

Gastric Cancer

Germany
Merck KGaA, Darmstadt, Germany

Completed

Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer

Gastric Cancer

Germany
Technical University of Munich

Completed

Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer

Gastric Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center; University Hospital Dresden

Active, not recruiting

OPPOSITE: Outcome Prediction Of Systemic Treatment in Esophagogastric Carcinoma (OPPOSITE)

Esophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm

Germany
Universitätsklinikum Hamburg-Eppendorf

Recruiting

Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc Resection (BEEPER)

Barrett Esophagus | Barrett Adenocarcinoma | Esophagus Neoplasm

United States, Germany
University of Ulm
Pfizer, Berlin Germany; Medac, Hamburg, Germany; Study Group Oncology of Gastrointestinal...

Completed

Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase (FOGT5)

Colorectal Cancer | Biopsy | Non Resectable Metastasis | Reference Lesion | Thymidylate Synthase Quantitation

Germany
AIO-Studien-gGmbH
iOMEDICO AG

Terminated

Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer (VOXEL)

Colorectal Neoplasms

Germany
Norgine

Completed

Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy

Colon Cancer

Germany
Norgine

Completed

Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies

Colon Cancer

Germany
Heidelberg University

Terminated

Pilot Study for Evaluation of the Need for Protective Ileostomy After Low Anterior Resection Due to Rectal Cancer

Rectal Cancer

Germany
Ralf Hofheinz
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsche... and other collaborators

Recruiting

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Rectal Cancer

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Economic Analysis of Robotic Rectal Resection in German Health Care System

Rectal Cancer

Germany
Photocure

Terminated

An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon

Colon Cancer

Germany
University of Ulm
Medac GmbH (Hamburg, Germany); Roche (Grenzach-Wyhlen, Germany)

Completed

Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer (FOGT1)

Rectal Cancer

Germany
Goethe University

Active, not recruiting

Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients (ACO/ARO/AIO-21)

Rectal Cancer

Germany
AIO-Studien-gGmbH
Roche Pharma AG; Immodulon Therapeutics Ltd

Recruiting

Atezolizumab in Patients With MSI-h/MMR-D Stage III Colorectal Cancer Ineligible for Oxaliplatin (ANTONIO)

Colorectal Cancer

Germany
University Hospital Schleswig-Holstein

Completed

Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer

Esophageal Cancer

Germany
Berlin School of Public Health
Federal Ministry of Health, Germany

Completed

Effect of a Website Offering Individual Patients' Experiences for Cancer Patients (DIPExRCT)

Colorectal Cancer

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

UICC Classification of Esophageal Cancer

Esophageal Cancer

Germany
PD Dr. med. Volker Heinemann
Amgen

Unknown

Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients

Colorectal Cancer | KRAS Wildtype | After Resection of Liver Metastases

Germany
Aesculap AG

Completed

CAIman 5 Articulating Maryland in coloRECTAL Cancer Surgery (CAIRECTAL)

Colorectal Cancer

Germany
Technical University of Munich
German Cancer Aid

Completed

Tertiary Prevention by Exercise in Colorectal Cancer Therapy (F-PROTECT)

Colorectal Cancer

Germany
CONKO-Studiengruppe
Eli Lilly and Company; medac GmbH

Completed

Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer (CONKO-101)

Esophageal Cancer

Germany

Clinical Trials on Gastrointestinal Neoplasms in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations